Nurix swings to quarterly net income of 549.81 million; revenue jumps to 673.06 million
Nurix reported revenue of $673.06 million for the three months ended Aug. 31, 2026, up 8,426% year over year. Net income swung to $549.81 million, or $4.73 per diluted share, from a net loss of $86.42 million. Research and development expenses fell to $79.26 million, while general and administrative expenses rose to $3